Protagonist Therapeutics (PTGX) Return on Invested Capital (2019 - 2025)
Historic Return on Invested Capital for Protagonist Therapeutics (PTGX) over the last 6 years, with Q3 2025 value amounting to 0.03%.
- Protagonist Therapeutics' Return on Invested Capital fell 2500.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.49% for FY2024, which is N/A changed from last year.
- Protagonist Therapeutics' Return on Invested Capital amounted to 0.03% in Q3 2025, which was down 2500.0% from 0.03% recorded in Q2 2025.
- Protagonist Therapeutics' Return on Invested Capital's 5-year high stood at 0.41% during Q4 2024, with a 5-year trough of 0.26% in Q1 2021.
- Its 3-year average for Return on Invested Capital is 0.14%, with a median of 0.16% in 2024.
- Per our database at Business Quant, Protagonist Therapeutics' Return on Invested Capital soared by 7800bps in 2021 and then plummeted by -2900bps in 2025.
- Quarter analysis of 3 years shows Protagonist Therapeutics' Return on Invested Capital stood at 0.26% in 2021, then skyrocketed by 259bps to 0.41% in 2024, then crashed by -93bps to 0.03% in 2025.
- Its Return on Invested Capital was 0.03% in Q3 2025, compared to 0.03% in Q2 2025 and 0.04% in Q1 2025.